134 related articles for article (PubMed ID: 9665414)
1. Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.
Nauck MS; Nissen H; Hoffmann MM; Herwig J; Pullinger CR; Averna M; Geisel J; Wieland H; März W
Clin Chem; 1998 Jul; 44(7):1388-96. PubMed ID: 9665414
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism.
Beil FU; Fojo SS; Brewer HB; Greten H; Beisiegel U
Eur J Clin Invest; 1992 Feb; 22(2):88-95. PubMed ID: 1349286
[TBL] [Abstract][Full Text] [Related]
3. A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient.
Okubo M; Hasegawa Y; Aoyama Y; Murase T
Atherosclerosis; 1997 Apr; 130(1-2):153-60. PubMed ID: 9126659
[TBL] [Abstract][Full Text] [Related]
4. A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama).
Inadera H; Hibino A; Kobayashi J; Kanzaki T; Shirai K; Yukawa S; Saito Y; Yoshida S
Biochem Biophys Res Commun; 1993 Jun; 193(3):1174-83. PubMed ID: 8323539
[TBL] [Abstract][Full Text] [Related]
5. Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons.
Olivecrona G; Beisiegel U
Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1545-9. PubMed ID: 9301634
[TBL] [Abstract][Full Text] [Related]
6. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.
Tuzgöl S; Bijvoet SM; Bruin T; Kastelein JJ; Hayden MR
J Med Genet; 1994 Aug; 31(8):622-6. PubMed ID: 7815420
[TBL] [Abstract][Full Text] [Related]
9. The genetics and molecular biology of apolipoprotein CII.
Hayden MR; Vergani C; Humphries SE; Kirby L; Shukin R; McLeod R
Adv Exp Med Biol; 1986; 201():241-51. PubMed ID: 3541518
[No Abstract] [Full Text] [Related]
10. Familial apolipoprotein CII deficiency: a preliminary analysis of the gene defect in two independent families.
Humphries SE; Williams L; Myklebost O; Stalenhoef AF; Demacker PN; Baggio G; Crepaldi G; Galton DJ; Williamson R
Hum Genet; 1984; 67(2):151-5. PubMed ID: 6547689
[TBL] [Abstract][Full Text] [Related]
11. The CII/CIII ratio of transferable apolipoprotein in primary and secondary hypertriglyceridemia.
Erkelens DW; Mocking JA
Clin Chim Acta; 1982 May; 121(1):59-65. PubMed ID: 7083594
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
Reina M; Brunzell JD; Deeb SS
J Lipid Res; 1992 Dec; 33(12):1823-32. PubMed ID: 1479292
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.
Yoldas Celik M; Canda E; Yazici H; Erdem F; Yuksel Yanbolu A; Atik Altinok Y; Pariltay E; Akin H; Kalkan Ucar S; Coker M
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1798-1806. PubMed ID: 38503616
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
[TBL] [Abstract][Full Text] [Related]
15. Structure of the human apolipoprotein C-II gene promoter.
Streicher R; Avci H; Munck M; Siemeister G; Geisel J; Weisshaar C; Müller-Wieland D; Krone W
Z Gastroenterol; 1996 Jun; 34 Suppl 3():49-50. PubMed ID: 8767460
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CII (apo CII) gene expression defect in an individual with familial apo CII deficiency.
Davison PJ; Stalenhoef AF; Humphries SE
Biochem Biophys Res Commun; 1987 Oct; 148(1):320-8. PubMed ID: 2445343
[TBL] [Abstract][Full Text] [Related]
17. Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari).
Crecchio C; Capurso A; Pepe G
Biochem Biophys Res Commun; 1990 May; 168(3):1118-27. PubMed ID: 1971748
[TBL] [Abstract][Full Text] [Related]
18. A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto).
Cox DW; Wills DE; Quan F; Ray PN
J Med Genet; 1988 Oct; 25(10):649-52. PubMed ID: 3225819
[TBL] [Abstract][Full Text] [Related]
19. Primary structure of the bovine analogues to human apolipoproteins CII and CIII. Studies on isoforms and evidence for proteolytic processing.
Bengtsson-Olivecrona G; Sletten K
Eur J Biochem; 1990 Sep; 192(2):515-21. PubMed ID: 2209608
[TBL] [Abstract][Full Text] [Related]
20. Identification of a splice-site mutation in the low density lipoprotein receptor gene by denaturing gradient gel electrophoresis.
Top B; van der Zee A; Havekes LM; van 't Hooft FM; Frants RR
Hum Genet; 1993 Jun; 91(5):480-4. PubMed ID: 8314561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
